Reveal the Cause of Genetic Diseases

A drop of blood can change your patient’s life. Support your patients fully with accurate information and helpful advice. A definitive diagnosis can bring great relief to patients and families, especially when they have been searching for answers a long time.


Search our Test Catalogue

Why do we believe in genetic testing?

We are dedicated to provide the complete spectrum of genetic, biochemical and biomarker analyses. Our commitment is to convert diagnostic data rapidly into the best solution for each individual patient. With the highest quality in medical interpretation, maintained by CentoMD®, the world’s largest mutation database for rare diseases, and global data sources, we continuously develop new and innovative products in molecular diagnostics.


Expert medical consultation

Advanced logistical solutions from sample sending to report administration

Global genotype-phenotype database for rare diseases CentoMD®

Short turnaround time and fast reporting


The user-friendly, online ordering and tracking portal.

Read more

The world´s largest mutation database of rare diseases.

Read more

Supports the execution of high-standard next generation sequencing diagnostics for human genetic laboratories. 

Read more

Diagnostic services

Whole exome sequencing provides information on all genes and identifies changes in DNA by focusing on the most informative regions of the genome, for a quick and cost-effective diagnostic solution.

Read More

CentoDx® focuses on the coding part of all genes associated with known clinical phenotypes, thereby comprising the complete clinical exome. It´s our largest NGS panel available, covering over 3,200 diseases.

Read More

Whole genome sequencing is ideal for finding novel mutations and identifying atypical presentations of a disease – especially for patients that exhibit a heterogeneous or atypical phenotype. 

Read More

Biomarkers play an essential role in the diagnosis, prediction and therapy monitoring of several metabolic diseases, especially when patients have accessible treatment options.  

Read More

NGS Panel Genomic avoids the additional costs of step wise analysis from deletion/duplication, follow up exome or genome sequencing, mitochondrial analysis, or analysis of new genes associated with the phenotype when new information surfaces.

Read More

CentoNIPT® offers genetic, non-invasive prenatal testing (NIPT) to screen for the most common fetal chromosomal abnormalities. Our test combines the latest next generation sequencing technology with expert medical reporting.

Read More

Additional services

Prenatal diagnosis allows for the sensitive identification of disease-causing mutations in at-risk families before birth and is offered for all diseases with congenital or early onset. Prenatal testing is given the highest priority at CENTOGENE.

Read More

Comparative genomic hybridization is a molecular cytogenetic method for analyzing copy number variations. CGH array allows us to quickly and efficiently determine the relative abundance of nucleic acid sequences in the target sample. 

Read More

Most people can be carriers of a disease causing change without knowing it. If both partners are carriers, they have a 25% risk of having an affected child with a recessive genetic disease and a 50% that the child will be a carrier like the parents. 

Read More

Hereditary cancer

Our medical and genetic experts can help determine which genetic testing is right to analyze if your patient has an increased risk for hereditary cancer.

Read more

Mitochondrial disease testing

CentoMito® helps to identify mitochondrial diseases to determine possible treatments and to suggest the best fitting therapy. 

Read more

Somatic mutations

Somatic mutation testing is of enormous help for survival and life-quality of cancer-affected patients and their families. Discover our oncogenetic panels and detect the most common cancer causing mutations.

Read more

Get in touch with our Partner Support

Our consultation service is available in several languages.

+49 (0) 381 - 80113 416

Mon. – Fri. 7 a.m.– 8 p.m. CET • Sat. – Sun. 9 a.m – 5 p.m. CET

For our US Partners:

+1 (617) 580-2102

Mon. – Fri. 9 a.m. – 5.30 p.m. EST